Neurotoxic effect of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-pyridinium (HP+), a major metabolite of haloperidol, in the dopaminergic system in vitro and in vivo

Biogenic Amines

Volumn 12, Issue 2, 1996, Pages 125-134

  Fang, J ^a   Lai, C T ^a   Yu, P H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CATECHOLAMINE; DOPAMINE; FREE RADICAL; HALOPERIDOL; NEUROLEPTIC AGENT; NEUROTOXIN; REDUCED HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE RELEASE; CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG METABOLISM; HUMAN; HUMAN CELL; MALE; MOTOR DYSFUNCTION; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PARKINSONISM; RAT; SYNAPSE; TARDIVE DYSKINESIA;

EID: 0029973802     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ablordeppey SY and Borne RF (1993) Detection of a neurotoxic quaternary pyridinium metabolites in the liver of haloperidol-treated rats. Pharmacol. Biochem. Behav. 46:739-744.
2. Baker GB and Dyck LE (1985) Neuronal transport of amines in vitro. In: Neuromethods: Neurochemistry II - Amines and their metabolites (eds: Boulton AA, Baker GB and Baker JM) New Jersey: Humana Press, pp457-534.
3. Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Pharmacological Basis of Therapeutics 7th edition (eds: Gilman GA, Goodman LS, Rall TW and Murad F), New York: Macmillan. pp. 385-445.
4. Bloomquist J, King E, Wright A, Mytilineou C, Kimura K, Castagnoli K and Castagnoli NJr (1994) 1-Methyl-4-phenylpyridinium-like neurotoxicity of pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies. J. Pharmacol Exp. Ther. 270:822-830.
5. Dom R (1967) Local glial reaction in the CNS of albino-rats in response to the administration of a neuroleptic drug (Butyrophenone). Acta Neurol. Belg. 67:755-762.
6. Fang J and Gorrod JW (1991) Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite. Toxicol. Lett. 59:117-123.
7. Fang J and Gorrod JW (1993) High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations. J. Chromatogr. 614:267-273.
8. +) towards cultured dopaminergic neuroblastoma cells. Psychopharmacol. (in press)
9. Fuller RW (1992) Comparison of MPTP and amphetamines as dopaminergic neurotoxins. Annals N.Y. Sci. 684: 87-95.
10. Gorrod JW (1978) Extra-hepatic metabolism of drugs, in: Drug Metabolism in Man. (ed: Gorrod JW and Beckett AH) London: Taylor and Francis Ltd. pp 157-174..
11. Gorrod JW and Fang J (1993) On the metabolism of haloperidol. Xenobiotica 23:495-508.
12. Grohmann R, Koch R and Schmidt LG (1990) Extrapyramidal symptoms in neuroleptic recipients. In: Adverse Drug Reactions, Basel, Birkhauser Verlag, pp 71-82.
13. Igarashi K and Castagnoli NJr (1992) Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 579:277-283.
14. Javitch JA, D'Amato RJ, Strittmatter SM and Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82:2173-2177.
15. Koizumi J and Shiraishi H (1973) Synaptic changes in the rabbit pallidum following long-term haloperidol administration. Folia. Psychiatr. Neurol. Jpn. 27: 51-57.
16. Kopin IJ, Markey SP (1988) MPTP toxicity: Implications for research in Parkinson's disease. Ann. Rev. Neurosci. 11:81-96.
17. Lancelot E, Callebert J, Plotkine M and Boulu RG (1995) Striatal dopamine participates in glutamate induced hydroxyl radical generation. NeuroReport 6:1033-1036.
18. Mantione CR, Zigmond MJ and Fisher A and Hanin I (1983) Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injections in rats. J. Neurochem. 41:251-255.
19. Meshul CK and Casey DE (1989) Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res. 489:338-346.
20. Mesnil M, Testa B and Jenner P (1984) Xenobiotic metabolism by brain monooxygenases and other cerebral enzymes. Adv. Drug Res. 13:195-207.
21. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunological Methods 65:55-63.
22. Naoi M, Dostert P, Yoshida M and Nagatsu T (1993) N-Methylated tetrahydroisoquinolines as dopaminergic neurotoxins. Adv. Neurol. 60: 212-217.
23. Nicklas WJ, Vyas I and Heillila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridi ne, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,23,6-tetrahydropyridine. Life Sci. 36:2503-2508.
24. Ramsay RR, Dadgar J, Trevor A and Singer TP (1986) Energy-driven uptake of N-methyl-4 phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. Life Sci. 39:581-588.
25. +, a pyridinium metabolite of haloperidol: a microdialysis study. In: Mechanism of drug action, (eds: Rollema H Westerink BHC and Drjfhout WJ) Groningen, Netherlands,. Univ. Groningen Press pp 367-369.
26. +-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies. J. Pharmacol. Exp. Ther. 268: 380-387.
27. See RE and Ellison G (1990) Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rat. Psychopharmacol. 100:404-412.
28. Subramanyam B, Rollema H, Woolf T and Castagnoli NJr (1990) Identification of a potentially neurotoxic pyridinium metabolite of haloperidot in rats. Biochem. Biophys. Res. Comm. 166:238-244.
29. Subramanyam B, Woolf T and Castagnoli NJr (1991) Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite. Chem. Res. Tox. 4:123-128.
30. Weddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, and putative relationship to tardive dyskinesia. Psychopharmacol. 101:431-447.